2seventy bio (TSVT) Competitors

89bio (NASDAQ:ETNB) and 2seventy bio (NASDAQ:TSVT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, community ranking, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Do institutionals and insiders hold more shares of ETNB or TSVT?

93.9% of 2seventy bio shares are owned by institutional investors. 2.8% of 89bio shares are owned by company insiders. Comparatively, 7.2% of 2seventy bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is ETNB or TSVT more profitable?

89bio has a net margin of 0.00% compared to 2seventy bio's net margin of -207.25%. 2seventy bio's return on equity of -53.65% beat 89bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
89bio	N/A	-59.58%	-52.21%
2seventy bio	-207.25%	-53.65%	-23.67%

Does the MarketBeat Community believe in ETNB or TSVT?

89bio received 82 more outperform votes than 2seventy bio when rated by MarketBeat users. Likewise, 64.46% of users gave 89bio an outperform vote while only 56.82% of users gave 2seventy bio an outperform vote.

Company	Underperform	Outperform
89bio	Outperform Votes 107 64.46%	Underperform Votes 59 35.54%
2seventy bio	Outperform Votes 25 56.82%	Underperform Votes 19 43.18%

Does the media prefer ETNB or TSVT?

In the previous week, 89bio had 18 more articles in the media than 2seventy bio. MarketBeat recorded 28 mentions for 89bio and 10 mentions for 2seventy bio. 2seventy bio's average media sentiment score of 0.15 beat 89bio's score of 0.00 indicating that 2seventy bio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
89bio	4 Very Positive mention(s)	5 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
2seventy bio	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger valuation & earnings, ETNB or TSVT?

89bio has higher earnings, but lower revenue than 2seventy bio. 89bio is trading at a lower price-to-earnings ratio than 2seventy bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
89bio	N/A	N/A	-$142.19M	-$2.91	-2.73
2seventy bio	$100.39M	1.81	-$217.57M	-$1.86	-1.89

Do analysts rate ETNB or TSVT?

89bio currently has a consensus target price of $30.33, suggesting a potential upside of 282.51%. 2seventy bio has a consensus target price of $9.00, suggesting a potential upside of 155.68%. Given 89bio's stronger consensus rating and higher probable upside, analysts clearly believe 89bio is more favorable than 2seventy bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
89bio	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
2seventy bio	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56

Which has more risk and volatility, ETNB or TSVT?

89bio has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, 2seventy bio has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500.

Summary

2seventy bio beats 89bio on 9 of the 16 factors compared between the two stocks.